Nothing Special   »   [go: up one dir, main page]

US20040077735A1 - Oil-in-water emulsion composition - Google Patents

Oil-in-water emulsion composition Download PDF

Info

Publication number
US20040077735A1
US20040077735A1 US10/682,873 US68287303A US2004077735A1 US 20040077735 A1 US20040077735 A1 US 20040077735A1 US 68287303 A US68287303 A US 68287303A US 2004077735 A1 US2004077735 A1 US 2004077735A1
Authority
US
United States
Prior art keywords
oil
gel
alcohol
aliphatic alcohol
emulsion composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/682,873
Other languages
English (en)
Inventor
Tohru Okamoto
Haruhiko Inoue
Hideo Nakajima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2000167708A external-priority patent/JP3829048B2/ja
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to US10/682,873 priority Critical patent/US20040077735A1/en
Publication of US20040077735A1 publication Critical patent/US20040077735A1/en
Priority to US12/249,657 priority patent/US8182827B2/en
Assigned to SHISEIDO COMPANY, LTD. reassignment SHISEIDO COMPANY, LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: INOUE, HARUHIKO, NAKAJIMA, HIDEO, OKAMOTO, TOHRU
Abandoned legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/0052Preparation of gels
    • B01J13/0065Preparation of gels containing an organic phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/062Oil-in-water emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Definitions

  • This invention relates in general to an oil-in-water emulsion composition, and more particularly to an oil-in-water emulsion composition which has superior stability over time and offers good usability.
  • an oil-in-water cream preparation emulsified with a non-ionic surfactant is prepared by forming an ⁇ -gel in which the molar ratio of the non-ionic surfactant and the higher aliphatic alcohol is 1:3 in the system to solidify the cream.
  • a sufficient amount of the ⁇ -gel needs to be formed to solidify the cream and prevent creaming; usually, 4 wt % or more of a amphiphilic substance such as a higher aliphatic alcohol and a non-ionic surfactant are blended in the ⁇ -gel.
  • an oil-in-water emulsion composition with superior stability over time and usability can be obtained by blending in a hydrophilic non-ionic surfactant or hydrophilic anionic surfactant and a higher aliphatic alcohol under specific conditions in the oil-in-water emulsion composition, thus completing the present invention.
  • the object of the present invention is to provide an oil-in-water emulsion composition which has superior stability over time and offers satisfactory sensations during use.
  • the present invention provides an oil-in-water emulsion composition containing a hydrophilic non-ionic surfactant or hydrophilic anionic surfactant, a higher aliphatic alcohol, water, and an oil ingredient(s) which meets the following conditions (1)-(4):
  • the hydrophilic non-ionic surfactant, the higher aliphatic alcohol, and water form a gel, and the gel thus formed has a transition temperature of 60° C. or higher.
  • the blend ratio of the hydrophilic non-ionic surfactant which forms said gel is 0.1 wt % or more and less than 0.5 wt % of the total amount of the oil-in-water emulsion composition.
  • the present invention provides said oil-in-water emulsion composition wherein said oil-in-water emulsion composition is a cream-like endermic liniment.
  • an alkyl ether type surfactant or an alkyl ester type surfactant with a linear chain alkyl group having 16 or more carbon atoms is preferable; examples include POE alkyl ethers such as POE stearyl ether and POE behenyl ether and POE alkyl esters such as polyethylene glycol monostearate. More preferable are surfactants with a HLB of 12-20; examples include POE alkyl ethers such as POE oleyl ether, POE stearyl ether, and POE behenyl ether.
  • Examples of the higher aliphatic alcohol used in the present invention include lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, cetostearyl alcohol. One, two or more of these are blended in.
  • Preferable is a mixture of two or more higher aliphatic alcohols. More preferable is a combination for which the melting point of the mixture is 60° C. or higher. If this melting point is lower than 60° C., then the temperature stability of the system decreases and creaming may occur, depending on the formula.
  • a combination of stearyl alcohol and behenyl alcohol is preferably used.
  • the oil-in-water emulsion composition of the present invention requires that the gel formed by the aforementioned higher aliphatic alcohol, the hydrophilic non-ionic surfactant, and water have a transition temperature of 60° C. or higher; preferably 65° C. or higher. If the transition temperature of this gel is lower than 60° C., then the temperature stability of the system decreases and creaming may occur.
  • This gel is usually an ⁇ -gel.
  • An ⁇ -gel is a gel prepared by adding water to a complex composed of a higher aliphatic alcohol and a hydrophilic non-ionic surfactant which assumes the ⁇ structure (“Physical Chemistry of Cetyl Alcohol”, Shoji Fukushima, Fragrance Journal Co., Ltd.).
  • the blend ratio of the hydrophilic non-ionic surfactant which forms the aforementioned gel needs to be 0.2-1.0 wt %, preferably 0.3-0.8 wt %, of the total amount of the oil-in-water emulsion composition. If the blend ratio is less than 0.2 wt % then the temperature stability of the system decreases and creaming may occur. If it is over 1.0 wt % then the sensation during application becomes heavy and a product with satisfactory usability cannot be obtained.
  • the blend ratio of the hydrophilic non-ionic surfactant and the higher aliphatic alcohol which form the gel is 1:3 (molar ratio).
  • gel refers to a complex composed of the lamella structure of the hydrophilic non-ionic surfactant and the higher alcohol formed in the water phase. The formation of a complex by the hydrophilic non-ionic surfactant and the higher alcohol can be verified with a DSC (differential scanning calorimeter).
  • the heat absorption curve of the sample prepared by mixing these two and dispersing them in water shows a single heat absorption peak which is at a higher temperature than the absorption peaks obtained by dissolving or dispersing either of them separately in water; when the blend ratio of the higher alcohol is low, (due to a shortage of the higher alcohol) the temperature of the heat absorption peak of the complex is low. This temperature rises as the blend ratio of the higher alcohol increases. When, after completion of the complex structure, the higher alcohol becomes in excess, this temperature plateaus and a peak due to the excess higher alcohol appears.
  • an extra amount of the higher aliphatic alcohol or an amphiphilic substance which is not involved in the formation of the aforementioned gel is contained and its blend ratio is 1-10 wt % of the total amount of the oil-in-water emulsion composition.
  • the description of the higher aliphatic alcohol in this case is the same as that of the higher aliphatic alcohol which is involved in the formation of the aforementioned ⁇ -gel.
  • the same higher aliphatic alcohol is added in excess. That is, since the molar composition ratio of the hydrophilic non-ionic surfactant and the higher aliphatic alcohol that form the gel is 1:3, the blend ratio value of the higher aliphatic alcohol which is involved in the ⁇ -gel is three times the amount (in moles) of the hydrophilic non-ionic surfactant multiplied by the average molecular weight of the higher aliphatic alcohol.
  • the blend ratio of the higher aliphatic alcohol must be higher than this value and the excess amount must be 1-10 wt %.
  • An amphiphilic substance other than a higher aliphatic alcohol can also be blended in.
  • the melting point of the amphiphilic substance is preferably 55° C. or higher, more preferably 60° C. or higher. If this melting point is lower than 55 ° C. then the temperature stability of the system decreases and creaming may occur.
  • preferable amphiphilic substances include glyceryl monoalkyl ether, monoglyceride, and batyl alcohol. When both the higher aliphatic alcohol and the amphiphilic substance which are not involved in the formation of the gel are blended in, the total blend ratio of the two is 1-1.0 wt %.
  • the blend ratio of the extra amount of the higher aliphatic alcohol or the amphiphilic substance other than a higher alcohol which is not involved in the formation of the gel needs to be 1.0-10 wt % of the total amount of the oil-in-water emulsion composition. If this blend ratio is less than 1.0 wt %, then the amount of the crystals of the extra higher alcohol or the amphiphilic substance is small and maintaining sufficient high temperature stability may not be possible. If the blend ratio is more than 10 wt % then the hardness becomes too high, depending on the composition, and the sensation during use becomes poor. Both can be blended in together, and the total blend ratio should be 1-10 wt %.
  • hydrophilic non-ionic surfactant which is an essential ingredient to form the gel
  • lipophilic non-ionic surfactants, cationic surfactants, anionic surfactants or amphiphilic surfactants can be blended in within the range that would not affect the effects of the present invention.
  • a hydrophilic non-ionic surfactant which is not involved in the formation of the gel can also be present.
  • the blend ratio of water in the oil-in-water emulsion composition of the present invention is in the range of 40-90 wt % of the total amount of the oil-in-water emulsion composition.
  • the oil ingredient depends on the product; the blend ratio is 5-50 wt % of the total amount of the oil-in-water emulsion composition.
  • the oil ingredient does not include the aforementioned higher aliphatic alcohol and the amphiphilic substance which are the essential ingredients.
  • N-acyl-L-glutamic acid salt or monoalkylphosphoric acid salt with a linear chain alkyl group having 16 or more carbon atoms is preferable; examples include monosodium N-stearoylglutamate, monosodium N-palmitoylglutamate, triethanolamine N-stearoylglutamate, and sodium cetylphosphate.
  • Examples of the higher aliphatic alcohol used in the present invention include lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, cetostearyl alcohol, etc. One, two or more of these are blended in.
  • Preferable is a mixture of two or more higher aliphatic alcohols. More preferable is a combination for which the melting point of the mixture is 60° C. or higher. If this melting point is lower than 60° C., then the temperature stability of the system decreases and creaming may occur, depending on the formula.
  • a combination of stearyl alcohol and behenyl alcohol is preferably used.
  • the oil-in-water emulsion composition of the present invention requires that the gel formed by the aforementioned higher aliphatic alcohol, the hydrophilic anionic surfactant, and water have a transition temperature of 60° C. or higher; preferably 65° C. or higher. If the transition temperature of this gel is lower than 60° C. then the temperature stability of the system decreases and creaming may occur.
  • This gel is usually an ⁇ -gel.
  • An ⁇ -gel is a gel prepared by adding water to a complex composed of a higher aliphatic alcohol and a hydrophilic surfactant which assumes the a structure (“Physical Chemistry of Cetyl Alcohol”, Shoji Fukushima, Fragrance Journal Co., Ltd.).
  • the blend ratio of the hydrophilic anionic surfactant which forms the aforementioned gel needs to be 0.1 wt % or more and less than 0.5 wt % of the total amount of the oil-in-water emulsion composition. If the blend ratio is less than 0.1 wt % then the temperature stability of the system decreases and creaming may occur. If it is over 0.5 wt % then the sensation during application becomes heavy and a product with satisfactory usability cannot be obtained.
  • the blend ratio of the hydrophilic anionic surfactant and the higher aliphatic alcohol which form the gel is 1:3 (molar ratio).
  • gel refers to a complex composed of the lamella structure of the hydrophilic anionic surfactant and the higher alcohol formed in the water phase. The formation of a complex by the hydrophilic anionic surfactant and the higher alcohol can be verified with a DSC (differential scanning calorimeter).
  • the heat absorption curve of the sample prepared by mixing these two and dispersing them in water shows a single heat absorption peak which is at a higher temperature than the absorption peaks obtained by dissolving or dispersing either of them separately in water; when the blend ratio of the higher alcohol is low, (due to a shortage of the higher alcohol) the temperature of the heat absorption peak of the complex is low. This temperature rises as the blend ratio of the higher alcohol increases. When, after completion of the complex structure, the higher alcohol becomes in excess, this temperature plateaus and a peak due to the excess higher alcohol appears.
  • an extra amount of the higher aliphatic alcohol or an amphiphilic substance which is not involved in the formation of the aforementioned gel is contained and its blend ratio is 0.5-10 wt % of the total amount of the oil-in-water emulsion composition.
  • the description of the higher aliphatic alcohol in this case is the same as that of the higher aliphatic alcohol which is involved in the formation of the aforementioned ⁇ -gel.
  • the same higher aliphatic alcohol is added in excess. That is, since the molar composition ratio of the hydrophilic anionic surfactant and the higher aliphatic alcohol that form the gel is 1:3, the blend ratio value of the higher aliphatic alcohol which is involved in the ⁇ -gel is three times the amount (in moles) of the hydrophilic anionic surfactant multiplied by the average molecular weight of the higher aliphatic alcohol. Therefore, the blend ratio of the higher aliphatic alcohol must be higher than this value and the excess amount must be 0.5-10 wt %.
  • amphiphilic substance other than a higher aliphatic alcohol can also be blended in.
  • the melting point of the amphiphilic substance is preferably 55° C. or higher, more preferably 60° C. or higher. If this melting point is lower than 55° C. then the temperature stability of the system decreases and creaming may occur.
  • preferable amphiphilic substances include glyceryl monoalkyl ether, monoglyceride, and batyl alcohol.
  • the blend ratio of the extra amount of the higher aliphatic alcohol which is not involved in the formation of the gel or the amphiphilic substance other than a higher alcohol needs to be 0.5-10 wt % of the total amount of the oil-in-water emulsion composition. If this blend ratio is less than 0.5 wt %, then the amount of the crystals of the extra higher alcohol or the amphiphilic substance is small and maintaining sufficient high temperature stability may not be possible. If the blend ratio is more than 10 wt % then the hardness becomes too high, depending on the composition, and the sensation during use becomes poor. Both can be blended in together, and the total blend ratio should be 1-10 wt %.
  • hydrophilic anionic surfactant which is an essential ingredient to form the gel
  • lipophilic non-ionic surfactants, cat ionic surfactants, anionic surfactants or amphiphilic surfactants can be blended in within the range that would not affect the effects of the present invention.
  • a hydrophilic anionic surfactant which is not involved in the formation of the gel can also be present.
  • the blend ratio of water in the oil-in-water emulsion composition of the present invention is in the range of 40-95 wt % of the total amount of the oil-in-water emulsion composition.
  • the oil ingredient depends on the product; the blend ratio is 3-50 wt % of the total amount of the oil-in-water emulsion composition.
  • the oil ingredient does not include the aforementioned higher aliphatic alcohol and the amphiphilic substance which are the essential ingredients.
  • Selection of the oil ingredient blended in the oil-in-water emulsion composition of the present invention is not limited in particular as long as it is an oil ingredient normally blended in an oil-in-water emulsion composition.
  • liquid oils/fats such as linseed oil, tsubaki oil, macademia oil, corn oil, mink oil, olive oil, avocado oil, sasanqua oil, castor oil, safflower oil, apricot kernel oil, cinnamon oil, jojoba oil, grape oil, sunflower oil, almond oil, rape seed oil, sesame oil, wheat germ oil, rice germ oil, cotton seed oil, rice bran oil, soybean oil, tea seed oil, evening primrose oil, egg yolk oil, neatsfoot tallow, liver oil, triglycerin, glyceryl trioctanoate, glyceryl triisopalmitate; liquid or solid fats/oils such as cocoyl oil, palm oil, and palm kernel oil; solid fats/oils such as
  • the present invention containing the aforementioned essential ingredients forms a gel composed of hydrophilic non-ionic surfactant or hydrophilic anionic surfactant-higher aliphatic alcohol-water in a cream-like oil-in-water emulsion composition. Since the blend ratio of the hydrophilic non-ionic surfactant is 1 wt % or less, the amount of the gel formed is small and therefore the sensation during use is refreshing and light. Since an extra amount of high-melting point higher aliphatic alcohol crystals is present along with the gel, sufficient solidification is achieved and creaming can be prevented despite the fact that the amount of the gel is small.
  • the present invention provides an oil-in-water emulsion composition with good stability over time and good usability although only a small amount of the surfactant is blended in.
  • the oil-in-water emulsion composition containing the aforementioned essential ingredients can be prepared by a conventional method in the form of an endermic liniment which is a cosmetic, drug, or quasi-drug. It is preferably used as an endermic liniment which in principle has the oil-in-water cream formulation wherein gel is formed in the system. Within a range which does not affect the effect of the present invention, common effective ingredients and base ingredients can be blended in.
  • Such effective ingredients include, if the endermic liniment of the present invention is used as a sun care product, for example, ultraviolet light absorbents.
  • ultraviolet light absorbents include benzoic acid type ultraviolet light absorbents such as paraamino benzoic acid; anthranilic acid type ultraviolet light absorbents such as methyl anthranilate; salicylic acid type ultraviolet light absorbents such as phenyl salicylate and octyl salicylate; cinnamic acid type ultraviolet light absorbents such as isopropyl paramethoxycinnamate, octyl paramethoxycinnamate, 2-ethylhexyl paramethoxycinnamate, glyceryl mono-2-ethylhexanoate diparamethoxycinnamate, and [4-bis(trimethylsiloxy)methylsilyl-3-methylbutyl]3,4,5-trimethoxy cinnamic ester; benzophenone type ultraviolet light absorbent
  • humectants can be blended in; examples include polyethylene glycol, propyleneglycol, di propyleneglycol, glycerin, diglycerine, 1,3-butylene glycol, hexylene glycol, xylitol, sorbitol, maltitol, maltose, D-mannitol, starch syrup, grape sugar, fruit sugar, lactose, sodium chondroitin sulfate, sodium hyaluronate, sodium adenosine phosphate, sodium lactate, bile salts, pyrrolidone carboxylic acid, glucosamine, and cyclodextrin.
  • vitamins which are used for purposes other than as an oil soluble antioxidant; hormones such as estradiol and ethynylestradiol; amino acids such as arginine, aspartic acid, cystine, cysteine, methionine, serine, leucine, and tryptophan; antiinflammatory agents such as allantoin, azulene, and glycyrrhetimic acid; whitening agents such as arbutin; astringents such as zinc oxide and tannic acid; refreshing agents such as menthol and camphor; sulfur, lysozyme chloride, pyridoxine hydrochloride, ⁇ -oryzanol, etc. can be blended in.
  • hormones such as estradiol and ethynylestradiol
  • amino acids such as arginine, aspartic acid, cystine, cysteine, methionine, serine, leucine, and tryptophan
  • antiinflammatory agents such as allantoin, azulene
  • extracts with a variety of medicinal effects can be blended in the endermic liniment of the present invention.
  • examples include houttuynia extract, cork tree bark extract, melilot extract, lamium album extract, glycyrrhiza extract, peony extract, saponaria officinalis extract, looffah extract, cinchona extract, saxifraga extract, sophora angustifolia extract, nuphar japonicum extract, anise extract, primula extract, rose extract, rehmannia root extract, lemon extract, lithospermum root extract, aloe extract, calamus extract, eucalyptus extract, equisetum arvense extract, sage extract, thyme extract, tea extract, seaweed extract, cucumber extract, syzygium aromaticum, raspberry extracts, melissa extracts, carrot extracts, marronnier extracts, peach extracts, peaches leaf extract, mul
  • Selection of the effective ingredients of the endermic liniment of the present invention is not limited to the aforementioned effective ingredients.
  • the aforementioned effective ingredients can be blended in the endermic liniment of the present invention independently or in combinations of two or more as necessary for a specific purpose.
  • base ingredients of the present invention in addition to the aforementioned essential ingredients, prior art base ingredients as required for the desired form can be blended in within the range which does not affect the effect of the present invention.
  • the following can be blended in the end ermic liniment: lower alcohols such as ethanol, propanol, and isopropanol; sterols such as cholesterol, sitosterol, phytosterol, and lanosterol; plant type polymers such as gum arabic, traganth gum, galactan, carob gum, guar gum, karaya gum, carrageenan, pectin, agar, quin seed (quince), algae colloid (brown alga extract), and starch (rice, corn, potato, wheat); microbe type polymers such as dextran, succinoglucan, and pluran; starch type polymers such as carboxymethyl starch and methylhydroxypropyl starch; animal type polymers such as collagen, casein, albumin, and gelatin cellulose type polymers such as methyl cellulose, nitro cellulose, ethyl cellulose, methylhydroxypropypl cellulose, hydroxyethyl cellulose, sodium cellulose sul
  • sequestering agents such as alanine, sodium edetate, sodium polyphosphate, sodium metaphosphate, and phosphoric acid
  • neutralizers such as 2-amino-2-methyl-1-propanol, 2-amino-2-methyl-1,3-propanediol, potassium hydroxide, sodium hydroxide, L-arginine, L-lysine, triethanolamine, and sodium carbonate
  • pH adjustment agents such as lactic acid, citric acid, glycolic acid, succinic acid, tartaric acid, dl-malic acid, potassium carbonate, sodium hydrogencarbonate, and ammonium hydrogencarbonate
  • antioxidants antimicrobial agents such as benzoic acid, salicylic acid, carbolic acid, para oxybenzoic acid ester, para chloro metacresol, hexachlorophene, benzalkonium chloride, chloride chloro
  • Examples 1-1 ⁇ 1-3 and Comparative examples 1-1 ⁇ 1-3 investigate the blend ratio of the hydrophilic non-ionic surfactant and the blend ratio of the higher aliphatic alcohol.
  • Examples 1-1 ⁇ 1-3 for which the blend ratios of the hydrophilic non-ionic surfactant and the higher aliphatic alcohol are both adequate, show good long-term stability and usability.
  • Comparative example 1-1 for which the blend ratio of the extra higher aliphatic alcohol which is not involved in the gel formation is less than 1 wt %, shows inferior long-term stability.
  • Comparative example 1-2 for which the blend ratio is over 10 wt %, shows inferior usability.
  • Comparative example 1-3 for which the blend ratio of the surfactant is 2 wt %, shows inferior usability.
  • POE (30) behenyl ether (a) 0.5 — — 0.1 — POE (20) behenyl ether (a) — 0.8 0.8 — POE (15) oleyl ether (a) — — — — 0.7 Behenyl alcohol (b) 3 2 2 4 — Stearyl alcohol (b) 2 2 — — — Cetostearyl alcohol (b) — — — — 4 Batyl alcohol (c) — — 2 — — Pentaerythritol 10 — — 10 — tetra-2-ethylhexanoate Di-2-ethylhexyl — 5 5 — 5 succinate Squalane 5 — — 5 Liquid petrolatum — 10 10 —
  • Examples 1-4 ⁇ 1-6 show good long-term stability and usability, which is the effect pertaining to the present invention.
  • Comparative example 1-4 has a blend ratio of the hydrophilic non-ionic surfactant of 0.1%, which is outside of the standard range, and shows inferior long-term stability.
  • Comparative example 1-5 the formula of the higher aliphatic alcohol-hydrophilic non-ionic surfactant-water system is set such that the gel transition temperature would be less than 60° C. This Comparative example 1-5 shows inferior long-term stability.
  • Examples 2-1 ⁇ 2-6 and Comparative examples 2-1 ⁇ 2-4 investigate the blend ratio of the hydrophilic anionic surfactant and the blend ratio of the higher aliphatic alcohol.
  • Comparative example 2-2 for which the blend ratio of the extra higher aliphatic alcohol which is not involved in the gel formation is over 10 wt %
  • Comparative example 2-4 for which the blend ratio of the surfactant is 1.5 wt %, shows inferior usability.
  • Examples 2-7 ⁇ 2-9 show good long-term stability and usability, which is the effect pertaining to the present invention.
  • Comparative example 2-5 has a blend ratio of the hydrophilic anionic surfactant of 0.1 wt %, which is outside of the standard range, and shows inferior long-term stability.
  • Comparative example 2-6 the formula of the higher aliphatic alcohol-hydrophilic anionic surfactant-water system is set such that the gel transition temperature would be less than 60° C. This Comparative example 2-6 shows inferior long-term stability.
  • the present invention is an oil-in-water emulsioncomposition containing a hydrophilic non-ionic surfactant or hydrophilic anionic surfactant, a higher aliphatic alcohol, water, and an oil ingredient which meets specific conditions.
  • This is an oil-in-water emulsion composition with good high temperature stability and usability, and can be used as a cream-like endermic liniment such as a cosmetic.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cosmetics (AREA)
US10/682,873 1999-07-27 2003-10-14 Oil-in-water emulsion composition Abandoned US20040077735A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/682,873 US20040077735A1 (en) 1999-07-27 2003-10-14 Oil-in-water emulsion composition
US12/249,657 US8182827B2 (en) 1999-07-27 2008-10-10 Oil-in-water emulsion composition

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP11-212430 1999-07-27
JP21243099 1999-07-27
JP2000167708A JP3829048B2 (ja) 2000-06-05 2000-06-05 水中油型乳化組成物
JP2000-167708 2000-06-05
US76361001A 2001-03-01 2001-03-01
US10/682,873 US20040077735A1 (en) 1999-07-27 2003-10-14 Oil-in-water emulsion composition

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US76361001A Division 1999-07-27 2001-03-01

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/249,657 Continuation US8182827B2 (en) 1999-07-27 2008-10-10 Oil-in-water emulsion composition

Publications (1)

Publication Number Publication Date
US20040077735A1 true US20040077735A1 (en) 2004-04-22

Family

ID=26519220

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/682,873 Abandoned US20040077735A1 (en) 1999-07-27 2003-10-14 Oil-in-water emulsion composition
US12/249,657 Expired - Fee Related US8182827B2 (en) 1999-07-27 2008-10-10 Oil-in-water emulsion composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/249,657 Expired - Fee Related US8182827B2 (en) 1999-07-27 2008-10-10 Oil-in-water emulsion composition

Country Status (6)

Country Link
US (2) US20040077735A1 (ko)
EP (1) EP1116483B1 (ko)
KR (1) KR100678364B1 (ko)
DE (1) DE60045332D1 (ko)
TW (1) TWI225405B (ko)
WO (1) WO2001006993A1 (ko)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090208594A1 (en) * 2008-02-18 2009-08-20 Mrs. Sima Cohen Cosmetic and dermatological composition for psoriatic skin treatment
US20110054041A1 (en) * 2008-03-11 2011-03-03 Ayumi Asai Oil-In-Water Type Cosmetic Emulsion
US20120164086A1 (en) * 2009-09-04 2012-06-28 Shiseido Company, Ltd. Production Method Of O/W Emulsion Composition
US20170105909A1 (en) * 2014-06-13 2017-04-20 Shiseido Company, Ltd. Alpha-gel-intermediate composition, and production method for alpha-gel-containing o/w emulsion cosmetic using said composition
US20170135914A1 (en) * 2014-06-13 2017-05-18 Shiseido Company, Ltd. a-GEL-INTERMEDIATE COMPOSITION, AND PRODUCTION METHOD FOR a-GEL-CONTAINING O/W EMULSION COSMETIC USING SAID COMPOSITION

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100650043B1 (ko) * 2006-01-31 2006-11-28 (주)아모레퍼시픽 피부탄력 개선용 유화 조성물
JP4767352B1 (ja) * 2010-03-17 2011-09-07 株式会社 資生堂 乳化組成物
WO2012117909A1 (ja) * 2011-03-01 2012-09-07 株式会社 資生堂 O/w乳化組成物の製造方法
EP2981245B1 (en) 2013-04-05 2023-03-01 The Procter & Gamble Company Personal care composition comprising a pre-emulsified formulation
US10806688B2 (en) 2014-10-03 2020-10-20 The Procter And Gamble Company Method of achieving improved volume and combability using an anti-dandruff personal care composition comprising a pre-emulsified formulation
US9993404B2 (en) 2015-01-15 2018-06-12 The Procter & Gamble Company Translucent hair conditioning composition
MX2018008913A (es) 2016-01-20 2019-05-06 Procter & Gamble Composicion acondicionadora del cabello que comprende eter monoalquil glicerilo.
EP3468530A4 (en) 2016-06-10 2020-03-11 Clarity Cosmetics Inc. NON-COMEDOGENOUS HAIR AND SCALP CARE FORMULATIONS AND METHOD OF USE
FR3060327B1 (fr) 2016-12-16 2020-02-21 L'oreal Emulsion h/e comprenant un alcool gras en c16-c30, un tensioactif anionique, une huile, une cire et un solvant hydrophile
KR102096011B1 (ko) * 2018-12-06 2020-04-02 주식회사 코리아나화장품 세라마이드를 함유하는 α-겔 구조의 화장료 조성물

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917886A (en) * 1982-10-07 1990-04-17 Ciba-Geigy Corporation Novel topically administrable pharmaceutical compositions
US5061481A (en) * 1989-03-20 1991-10-29 Kobayashi Kose Co., Ltd. Cosmetic composition having acryl-silicone graft copolymer
US5693255A (en) * 1993-03-15 1997-12-02 Shiseido Co., Ltd. Oil-in-water type emulsion composition
US6086787A (en) * 1990-03-30 2000-07-11 Henkel Kommanditgesellschaft Auf Aktien Process for the production of oil-in-water creams

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767625A (en) * 1985-09-02 1988-08-30 Kao Corporation Lamella type single phase liquid crystal composition and oil-base cosmetic compositions using the same
JPS63221835A (ja) * 1987-03-09 1988-09-14 Lion Corp 安定な水中油型エマルジヨンの製造方法
JPH09151112A (ja) * 1995-11-30 1997-06-10 Noevir Co Ltd 微細エマルション組成物
WO1999040887A1 (fr) 1998-02-10 1999-08-19 Shiseido Company, Ltd. Composition emulsionnees de type aqueux

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917886A (en) * 1982-10-07 1990-04-17 Ciba-Geigy Corporation Novel topically administrable pharmaceutical compositions
US5061481A (en) * 1989-03-20 1991-10-29 Kobayashi Kose Co., Ltd. Cosmetic composition having acryl-silicone graft copolymer
US6086787A (en) * 1990-03-30 2000-07-11 Henkel Kommanditgesellschaft Auf Aktien Process for the production of oil-in-water creams
US5693255A (en) * 1993-03-15 1997-12-02 Shiseido Co., Ltd. Oil-in-water type emulsion composition

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090208594A1 (en) * 2008-02-18 2009-08-20 Mrs. Sima Cohen Cosmetic and dermatological composition for psoriatic skin treatment
US20110054041A1 (en) * 2008-03-11 2011-03-03 Ayumi Asai Oil-In-Water Type Cosmetic Emulsion
CN102006851A (zh) * 2008-03-11 2011-04-06 株式会社资生堂 水包油型乳化化妆品
US8765821B2 (en) * 2008-03-11 2014-07-01 Shiseido Company, Ltd. Oil-in-water type cosmetic emulsion
US20120164086A1 (en) * 2009-09-04 2012-06-28 Shiseido Company, Ltd. Production Method Of O/W Emulsion Composition
US20170105909A1 (en) * 2014-06-13 2017-04-20 Shiseido Company, Ltd. Alpha-gel-intermediate composition, and production method for alpha-gel-containing o/w emulsion cosmetic using said composition
US20170135914A1 (en) * 2014-06-13 2017-05-18 Shiseido Company, Ltd. a-GEL-INTERMEDIATE COMPOSITION, AND PRODUCTION METHOD FOR a-GEL-CONTAINING O/W EMULSION COSMETIC USING SAID COMPOSITION
US10231909B2 (en) * 2014-06-13 2019-03-19 Shiseido Company, Ltd. α-gel-intermediate composition, and production method for α-gel-containing O/W emulsion cosmetic using said composition
US10835460B2 (en) * 2014-06-13 2020-11-17 Shiseido Company, Ltd. α-Gel-intermediate composition, and production method for α-gel-containing O/W emulsion cosmetic using said composition

Also Published As

Publication number Publication date
EP1116483B1 (en) 2010-12-08
US8182827B2 (en) 2012-05-22
KR20010075028A (ko) 2001-08-09
DE60045332D1 (de) 2011-01-20
EP1116483A1 (en) 2001-07-18
TWI225405B (en) 2004-12-21
US20090041811A1 (en) 2009-02-12
KR100678364B1 (ko) 2007-02-05
WO2001006993A1 (fr) 2001-02-01
EP1116483A4 (en) 2006-02-08

Similar Documents

Publication Publication Date Title
US8182827B2 (en) Oil-in-water emulsion composition
JP3609834B2 (ja) 皮膚外用剤
US20120251480A1 (en) Oil-In-Water External Skin Preparation
JP5718010B2 (ja) 水中油型乳化組成物
KR100760167B1 (ko) 수중유형 유화 조성물
US20190029932A1 (en) Ripple-phase containing composition, alpha-gel formation composition, external skin care composition using alpha-gel formation composition, and alpha-gel composition using alpha-gel formation composition
US5827920A (en) Emulsion composition
JP2008024630A (ja) 油中水型乳化組成物
JP3829048B2 (ja) 水中油型乳化組成物
JPH11199465A (ja) 皮膚外用剤
JP2014047158A (ja) 油中水型乳化組成物及びその製造方法
JP5588164B2 (ja) 水中油型乳化皮膚化粧料
JP4152301B2 (ja) 水中油型乳化組成物
JPH09124878A (ja) ゲル組成物
JPH0987130A (ja) 乳化組成物
JP3829049B2 (ja) 水中油型乳化組成物
JP3539534B2 (ja) 皮膚外用剤
JP5547123B2 (ja) 油中水型乳化化粧料
JP4562213B2 (ja) 水中油型乳化組成物
JP3587320B2 (ja) 乳化組成物
JP3634139B2 (ja) 水中油型乳化組成物
JPH1095706A (ja) 乳化剤組成物
JP3713406B2 (ja) 皮膚外用ゲル製剤
JPH11349439A (ja) 水中油型乳化組成物
JPH09263510A (ja) 乳化組成物

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: SHISEIDO COMPANY, LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:OKAMOTO, TOHRU;INOUE, HARUHIKO;NAKAJIMA, HIDEO;REEL/FRAME:031049/0629

Effective date: 20010209